Washon Innostars gathered a group of well-known entrepreneurs, investors, well-known professors, and technical experts who could be your business mentors.
Dan Shechtman (born January 24, 1941) is the Philip Tobias Professor of Materials Science at the Technion – Israel Institute of Technology, an Associate of the US Department of Energy’s Ames Laboratory, and Professor of Materials Science at Iowa State University. On April 8, 1982, while on sabbatical at the U.S. National Bureau of Standards in Washington, D.C., Shechtman discovered the icosahedral phase, which opened the new field of quasiperiodic crystals. Shechtman was awarded the 2011 Nobel Prize in Chemistry for the discovery of quasicrystals, making him one of six Israelis who have won the Nobel Prize in Chemistry.
Craig Cameron Mello (born October 18, 1960) is an American biologist and professor of molecular medicine at the University of Massachusetts Medical School in Worcester, Massachusetts. He was awarded the 2006 Nobel Prize for Physiology or Medicine, along with Andrew Z. Fire, for the discovery of RNA interference. This research was conducted at the University of Massachusetts Medical School and published in 1998. Mello has been a Howard Hughes Medical Institute investigator since 2000.
Jim Cheng has over 25 years experience as a technology entrepreneur, angel/private capital investor, business leader and a senior state government executive. He currently advises several Angel/Private Equity Investment organizations, is Of Counsel to the Lee and Hayes Law Firm and teaches Entrepreneurial Finance at the UVA Engineering School. Plus, he currently serves on numerous boards and advisory boards of non-profit organizations and for-profit startups and mid-sized companies. In addition to actively supporting technology startups and entrepreneurs in the region, he continues to advise companies on economic development issues and on investing in the US.
Terry Hsiao is a well-recognized entrepreneur in the mobile telecommunications industry. Since 2000, he has founded three start-ups including InphoMatch (later rebranded Mobile 365) which was acquired by Sybase (Now SAP) for $425M in 2006. Currently, he serves as CEO of Hooks Mobile, a cloud services provider for mobile apps and games. Mr. Hsiao has been appointed by the Governor in Virginia, Bob McDonnell, to serve on the Board of Innovation and Entrepreneurship Investment Authority in Virginia. Hsiao also serves as a member on the Board of Governors at MIT Sloan School of Management, Monte Jade DC Chapter, and Advisory Board at Rutgers University College of Engineering and the Confucius Institute at George Mason University (GMU). Hsiao has a Honors BSEE from Rutgers University and SM (MBA) from MIT Sloan School of Management.
Steven Chen is an investor, serial entrepreneur and mentor. Experience includes CEO of an Intel Capital portfolio company, 20x exit, CTO and m&a for a $150M public company, $300M+ SBIR contracts, chairman of an IEEE standard working group. Currently founder of 2 startups, investor of 10+ companies and advisor for multiple companies. Specialties: cyber security, wireless, sensor networks, M2M, physical security, energy management, Small Business Innovation Research (SBIR).
Ira Koretsky, President of The Chief Storyteller. The Chief Storyteller helps you accelerate your success in U.S. markets. Over the past 10 years, we have consulted to, trained, and presented to more than 26,000 people in the U.S. and in 8 countries. We reframe your spoken, print, email, and social media communications to more effectively engage U.S. audiences. Using a variety of proven processes and easy-to-use tools, we help you increase prospecting success with traditional and social media communications programs. We blend the best of your communications and presentation skills with U.S. styles and expectations. Market specialties include Federal Government, Security, IT/Telecom, Bio, Health, Science, and Energy.
Jianwei Zhang is professor and head of TAMS, Department of Informatics, University of Hamburg, Germany. He received both his Bachelor of Engineering (1986, with distinction) and Master of Engineering (1989) at the Department of Computer Science of Tsinghua University, Beijing, China, his PhD (1994) at the Institute of Real-Time Computer Systems and Robotics, Department of Computer Science, University of Karlsruhe, Germany, and Habilitation (2000) at the Faculty of Technology, University of Bielefeld, Germany. His research interests are AI, cognitive robotics, sensor fusion, dexterous manipulation and multimodal robot learning, Industry4.0 etc. In these areas he has published about 300 journal and conference papers (with 4 Best Paper Awards), technical reports, four book chapters and three research monographs. He has been coordinating numerous collaborative research projects of EU and German Research Council, including the Transregio-SFB TRR169 “Crossmodal Learning”. He holds 37 patents on service robot components and systems. Jianwei Zhang is life-long Academician of Academy of Sciences in Hamburg. He is the General Chairs of IEEE MFI 2012 and IEEE/RSJ IROS 2015, IEEE Robotics and Automation Society AdCom (2013-2015).
Dr. Zhiyun Bo MD Professor, a chief physician, who is the inventor of “Bo’s Abdominal Acupuncture therapeutics” and discoverer of “Congenital Meridian System” and “Shenque Regulator Control System”, also the implementer of national standard of Abdominal Acupuncture therapeutics and prizewinner of the first batch of extraordinary contribution award set for TCM inheritance. He is one of the selected authors in “Three Hundreds Original Project” which set by Ministry of Culture and member of “hundreds of old famous”. Prof. Bo holds the post of consultant of WTCMA naturopathy committee, IOM of Abdominal Acupuncture in USA, Acupuncture Institute in Singapore, TCM specialist Union in Europe. He’s the chairman of Abdominal Acupuncture committee in CAI and head of Bo’s Abdominal Acupuncture institute in Peking and Guangdong, while also the visiting professor of Guangxi and Fujian TCM University.
Dr. Guoying Yu got his BS, MS and PhD in the Henan Normal University, Yunnan University, and The Chinese Academy of Sciences in the Peoples’ Republic of China respectively. He joined in University of Pittsburgh and completed his research fellow training on pulmonary. Dr. Yu focuses on investigations into the pathogenesis of idiopathic pulmonary fibrosis (IPF). To gain insight into the pathogenesis of IPF, Based on gene expression profiling of IPF lungs compared to normal controls, we focus on the genes that exhibited altered expression in IPF under the rationale that genes likely contribute to the development of pulmonary fibrosis. Currently Dr Yu is focusing on exploring the role and regulation of MMP19, miR-29 and thyroid hormone in human pulmonary fibrosis. He made the novel insights that microRNA mir-29 is decreased in expression in patients with IPF, therapeutic delivery of these miR-29 mimics during bleomycin-induced pulmonary fibrosis can increase level of miR-29 in vivo and restores endogenous miR-29 function and blocking and reversing pulmonary fibrosis. Most recently, we first investigated the role of thyroid hormone in pulmonary fibrosis and demonstrated that DIO2 was one of the most upregulated genes that differentiated patients with IPF from controls, and delivery of thyroid hormone can cure and reverse the pulmonary fibrosis shedding light on new therapy for this incurable disease.
Dr. Dapeng Cui, Post Doctor, Center of Sustainable Development, China Social Science Academy; Ph D of Economics, Renmin University, Population, Resources & Environment; Master of Law, Peking University, International Relation; Bachelor of Engineering, Tsinghua University, Environmental Engineering; Advanced Program on International law in Erasmus University, Rotterdam; Advanced Program on Gerontology in UN Institute of Gerontology in Malta.
Now Director, Low Carbon Research Group, CSSD and East-West Think Tank Information center; Professor(part time), Environment School, Jiangnan University; Research Fellow(part time), Center of Sustainable Development, CASS; Promotion on Green low carbon smart sponge city, Bio-agriculture(in Desert & Ocean) and healthcare industry, Sustainability in all aspects with international cooperation, Facilitate all resource such as Policy, High-tech, Investment, Teamwork, Strategy & NGO Platform etc. for green pilot projects.
Published books includes: <the Political-economic Analysis on International Climate Cooperation>, the Business Press; <Low Carbon Economy> &< Low Carbon Development>, China Environmental Science Press; < Low Carbon Innovation>&< Low Carbon Cartoon>, Posts and Telecom Press, etc.
Expert Experience listed below:
2016, Host of Taihu International Culture Forum on Human Community in Macau
2015, Expert of delegation to Australia for Bio-agriculture and Healthcare investigation and exchange.
2014, Member of expert group, UNDP Biomass Energy Kaidi Project, Investigation in Chongzuo & Beihai of Guangxi Autonomous Zone for Sugarcane, Eucalypt, Cassava and Eco-recycle Farm.
2013, Expert of visit group, IGEA delegation to Israel to investigate Eco-agriculture and Desert & sea cultivation as well as irrigation technology.
2012, Member of delegation of Chinese NGOs to UN Rio+20 Summit conference on Sustainable development
2011, Organizer of Project “Sino-German cooperation on Low Carbon Cities between Wuxi & Dusseldorf”
2010, Member of Jury, Low carbon Eco-City planning in Xiangshan Damu Bay, Ningbo.
Dr. Jielou Liao Undergraduate and Ph.D. graduated from University of Science and Technology of China, Duke University MBA. Duke University Senior Visiting Professor, Visiting Professor of North Carolina State University, Professor of University of Science and Technology of China, Chief Executive Officer of Nahua Medical Technology Co., Ltd., Chairman of Jeffrey (Anhui) Environmental Protection New Energy Technology Co., Ltd., China Chamber of Commerce Science and Technology Innovation Committee Members. For many years engaged in innovative medicine research and development, management and investment work. Organized and led sixteen potential anti-cancer, cardiovascular disease, Alzheimer’s disease and anti-aging and other innovative medicine research and clinical trials. Currently six of them carry out 1-3 clinical trials in United States and China. Committed to a number of countries and provincial and municipal science and technology projects and natural science fund projects. He served as Senior Manager of GSK, Senior Director and Chief Scientist of TTPharma Pharmaceuticals, Co-Chairman of the North Carolina Biotechnology and Pharmacy Committee. Published 26 patents, more than 100 articles of scientific papers.
Liping Zhang, senior IP consultant and China country manager of Dolcera. As the China country manager, Liping manages Dolcera’s China business development efforts, including financing as well. Prior to Dolcera, Liping was a research analyst in leading financial services institutions, such as Glass Lewis & Co., Morgan Stanley. Liping holds a PhD degree in Enterpreneurship and Innovation from Tsinghua University and MIT, a master degree in management from Tsinghua University and a bachelor degree from Nankai University.